We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.21B
AUM Growth
+$330M
Cap. Flow
+$275M
Cap. Flow %
22.73%
Top 10 Hldgs %
36.41%
Holding
4,516
New
1,790
Increased
1,264
Reduced
722
Closed
680

Sector Composition

Rank Sector Weight
1 Financials 6.31%
2 Technology 5.59%
3 Industrials 5.06%
4 Consumer Discretionary 3.68%
5 Healthcare 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPJ
3451
DELISTED
Highpower International Inc
HPJ
$4K ﹤0.01%
+964
New +$4.31K
MTL
3452
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$4K ﹤0.01%
+700
New +$3.59K
PHII
3453
DELISTED
PHI, Inc.
PHII
$4K ﹤0.01%
300
+199
+197% +$2.14K
ARLZ
3454
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$4K ﹤0.01%
1,400
+1,100
+367% +$1.47K
AFMD
3455
DELISTED
Affimed
AFMD
$3K ﹤0.01%
+119
New +$2.58K
ALKS icon
3456
Alkermes
ALKS
$8.33B
$3K ﹤0.01%
64
-220
-77% -$11.8K
AVK
3457
Advent Convertible and Income Fund
AVK
$562M
$3K ﹤0.01%
+205
New +$3.23K
AXR icon
3458
AMREP Corp
AXR
$121M
$3K ﹤0.01%
470
+370
+370% +$2.55K
CBUS icon
3459
Cibus
CBUS
$147M
$3K ﹤0.01%
+3
New +$2.55K
CII icon
3460
BlackRock Enhanced Captial and Income Fund
CII
$1.01B
$3K ﹤0.01%
+200
New +$3.04K
CLMB icon
3461
Climb Global Solutions
CLMB
$500M
$3K ﹤0.01%
+868
New +$3.47K
CPIX icon
3462
Cumberland Pharmaceuticals
CPIX
$116M
$3K ﹤0.01%
434
-588
-58% -$4.07K
CVV icon
3463
CVD Equipment Corp
CVV
$57.7M
$3K ﹤0.01%
+268
New +$2.99K
DD icon
3464
DuPont de Nemours
DD
$19.3B
$3K ﹤0.01%
17
DKS icon
3465
Dick's Sporting Goods
DKS
$18B
$3K ﹤0.01%
+125
New +$3.98K
DSX icon
3466
Diana Shipping
DSX
$311M
$3K ﹤0.01%
1,197
-6,661
-85% -$18.5K
EMBJ
3467
Embraer S.A. ADS
EMBJ
$12.5B
$3K ﹤0.01%
118
-224
-65% -$4.78K
EVG
3468
Eaton Vance Short Duration Diversified Income Fund
EVG
$143M
$3K ﹤0.01%
+200
New +$2.85K
FTK icon
3469
Flotek Industries
FTK
$1.02B
$3K ﹤0.01%
+97
New +$3.84K
FUN icon
3470
Cedar Fair
FUN
$1.85B
$3K ﹤0.01%
+46
New +$3.08K
FUNC icon
3471
First United
FUNC
$288M
$3K ﹤0.01%
190
-272
-59% -$4.14K
GDS icon
3472
GDS Holdings
GDS
$6.69B
$3K ﹤0.01%
249
-11,523
-98% -$112K
GILT icon
3473
Gilat Satellite Networks
GILT
$899M
$3K ﹤0.01%
+471
New +$2.65K
GWRE icon
3474
Guidewire Software
GWRE
$13.3B
$3K ﹤0.01%
39
-361
-90% -$26.4K
STRR
3475
Star Equity Holdings
STRR
$40.6M
$3K ﹤0.01%
207
-1,315
-86% -$18.6K

Similar funds

Tower Research Capital (TRC)'s Q3 2017 Portfolio in Review

As of Q3 2017, Tower Research Capital (TRC) held 4,516 positions worth $1.21B, up 37% from $881M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tower Research Capital (TRC) deployed $275M of net new capital in Q3 2017, opening 1,790 new positions and adding to 1,264 existing holdings. Its largest new stake was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.

By sector, the portfolio is most concentrated in Financials at 6.3% of assets, up from 2.1% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $60M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2017 buy was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $135M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $60M.
  • Tower Research Capital (TRC) fully exited State Street Consumer Discretionary Select Sector SPDR ETF in Q3 2017, selling an estimated $17.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 36% of its $1.21B portfolio in Q3 2017.
  • Tower Research Capital (TRC) opened 1,790 new positions and closed 680 in Q3 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.21B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.